We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+1.53%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$988M
AUM Growth
-$950M
Cap. Flow
-$941M
Cap. Flow %
-95.22%
Top 10 Hldgs %
46.58%
Holding
205
New
16
Increased
16
Reduced
38
Closed
131

Top Buys

Rank Stock Value
1
QTRX icon
Quanterix
QTRX
+$23.5M
2
OM icon
Outset Medical
OM
+$11.4M
3
LIVN icon
LivaNova
LIVN
+$8.76M
4
CUTR
Cutera, Inc.
CUTR
+$5.89M
5
RCM
R1 RCM Inc. Common Stock
RCM
+$4.31M

Top Sells

Rank Stock Value
1
INSP icon
Inspire Medical Systems
INSP
+$26.8M
2
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$25.3M
3
BIIB icon
Biogen
BIIB
+$17.4M
4
ESTA icon
Establishment Labs
ESTA
+$15.9M
5
VRAY
ViewRay, Inc.
VRAY
+$14.1M

Sector Composition

Rank Sector Weight
1 Healthcare 31.61%
2 Industrials 1.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RGEN icon
151
PUT
Repligen
RGEN
$9.35B
– –
-19,800
Closed -$3.35M
RLMD icon
152
CALL
Relmada Therapeutics
RLMD
$503M
– –
-20,000
Closed -$69.8K
RLMD icon
153
Relmada Therapeutics
RLMD
$503M
– –
-22,233
Closed -$77.6K
SEER icon
154
PUT
Seer Inc
SEER
$118M
– –
-250,000
Closed -$1.45M
SKIN icon
155
PUT
SkinHealth Systems
SKIN
$84.2M
– –
-200,000
Closed -$1.82M
SMMT icon
156
CALL
Summit Therapeutics
SMMT
$12B
– –
-200,000
Closed -$850K
SRPT icon
157
CALL
Sarepta Therapeutics
SRPT
$1.94B
– –
-200,000
Closed -$25.9M
STAA icon
158
STAAR Surgical
STAA
$1.27B
– –
-173,310
Closed -$11.3M
STE icon
159
Steris
STE
$23.1B
– –
-15,500
Closed -$2.86M
STRO icon
160
Sutro Biopharma
STRO
$353M
– –
-3,141
Closed -$254K
STVN icon
161
Stevanato
STVN
$5.8B
– –
-42,000
Closed -$755K
SVRA icon
162
Savara
SVRA
$1.17B
– –
-95,014
Closed -$147K
SYK icon
163
PUT
Stryker
SYK
$133B
– –
-90,000
Closed -$22M
SYRE icon
164
Spyre Therapeutics
SYRE
$9.18B
– –
-41,948
Closed -$472K
TERN
165
DELISTED
Terns Pharmaceuticals
TERN
– –
-605,079
Closed -$6.16M
TGTX icon
166
CALL
TG Therapeutics
TGTX
$7.58B
– –
-250,000
Closed -$2.96M
TGTX icon
167
TG Therapeutics
TGTX
$7.58B
– –
-504,829
Closed -$5.97M
TGTX icon
168
PUT
TG Therapeutics
TGTX
$7.58B
– –
-593,100
Closed -$7.02M
TMDX icon
169
PUT
Transmedics
TMDX
$3.02B
– –
-90,000
Closed -$5.55M
TMO icon
170
PUT
Thermo Fisher Scientific
TMO
$223B
– –
-40,000
Closed -$22M
TSVT
171
DELISTED
2seventy bio
TSVT
– –
-251,309
Closed -$2.35M
UNH icon
172
PUT
UnitedHealth
UNH
$364B
– –
-60,000
Closed -$31.8M
UTHR icon
173
United Therapeutics
UTHR
$21.9B
– –
-36,333
Closed -$10.1M
VERA icon
174
Vera Therapeutics
VERA
$2.16B
– –
-35,372
Closed -$684K
VRDN icon
175
Viridian Therapeutics
VRDN
$2.59B
– –
-35,003
Closed -$1.02M
5 6
7
8 9

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q1 2023 Portfolio in Review

As of Q1 2023, Pura Vida Investments held 205 positions worth $988M, down 49% from $1.94B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Pura Vida Investments withdrew a net $941M in Q1 2023, closing 131 positions and reducing 38 holdings. Its most notable exit was IVERIC bio, Inc. Common Stock, an estimated $25.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 27% a quarter earlier, followed by Industrials.

Against the trend, Pura Vida Investments opened a new position in Repligen worth $2.56M.

  • Pura Vida Investments's largest Q1 2023 buy was Repligen: 15,200 shares worth $2.56M.
  • Pura Vida Investments added most to Quanterix in Q1 2023, an estimated $23.5M increase.
  • Pura Vida Investments's biggest Q1 2023 reduction was Inspire Medical Systems, cutting an estimated $26.8M.
  • Pura Vida Investments fully exited IVERIC bio, Inc. Common Stock in Q1 2023, selling an estimated $25.3M.
  • Pura Vida Investments's ten largest holdings make up 47% of its $988M portfolio in Q1 2023.
  • Pura Vida Investments opened 16 new positions and closed 131 in Q1 2023.
  • Pura Vida Investments's portfolio value fell 49% quarter-over-quarter to $988M.

Based on Pura Vida Investments's 13F filing for Q1 2023, filed 15 May 2023.